Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

As Recalls Multiply, EU Agency Studies How To Rid Chinese Firm’s Valsartan API Of Probable Carcinogen

Jul 20 2018

• By Bowman Cox

A worker examines a chemical raw materials tank

Related Content

EU Regulators Recall Valsartan Products Produced In China

Jul 06 2018

Related Companies

Zhejiang Huahai Pharmaceutical Co., Ltd.

Teva Pharmaceutical Industries Ltd.

Additional Topics

Europe China Asia Pacific United States Japan Manufacturing Quality Recalls Drug Safety BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.